Abstract
Acquired resistance to cisplatin (DDP) is a major clinical problem in the treatment of ovarian, testicular, and head and neck carcinomas; decreased accumulation of DDP is the most consistently observed alteration in resistant cells. It has been postulated that DDP enters the cell by passive diffusion based on the observations that DDP accumulation is proportional to the drug concentration, accumulation is not saturable, and that structural analogs of DDP do not inhibit accumulation. However, recent studies show that DDP accumulation can be specifically stimulated or inhibited by pharmacological agents and the activation of signal transduction pathways. This paper reviews the existing data on the mechanism of DDP accumulation and develops the postulate that some component of transport occurs through a gated ion channel.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gately, D., Howell, S. Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67, 1171–1176 (1993). https://doi.org/10.1038/bjc.1993.221
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.221
This article is cited by
-
Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
Hereditas (2023)
-
Emerging and established therapies for chemotherapy-induced ototoxicity
Journal of Cancer Survivorship (2023)
-
Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions
Medical Oncology (2023)
-
In vitro and in vivo accumulation of the anticancer Ru complexes [RuII(cym)(HQ)Cl] and [RuII(cym)(PCA)Cl]Cl
JBIC Journal of Biological Inorganic Chemistry (2023)
-
The rediscovery of platinum-based cancer therapy
Nature Reviews Cancer (2021)